APA (7th ed.) Citation

Martinez, S., Sindu, D., Nailor, M. D., Cherrier, L., Tokman, S., Walia, R., & Goodlet, K. J. (2024). Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious Disease, 26(3), 1. https://doi.org/10.1111/tid.14279

Chicago Style (17th ed.) Citation

Martinez, Sydni, Devika Sindu, Michael D. Nailor, Lauren Cherrier, Sofya Tokman, Rajat Walia, and Kellie J. Goodlet. "Evaluating the Efficacy and Safety of Letermovir Compared to Valganciclovir for the Prevention of Human Cytomegalovirus Disease in Adult Lung Transplant Recipients." Transplant Infectious Disease 26, no. 3 (2024): 1. https://doi.org/10.1111/tid.14279.

MLA (9th ed.) Citation

Martinez, Sydni, et al. "Evaluating the Efficacy and Safety of Letermovir Compared to Valganciclovir for the Prevention of Human Cytomegalovirus Disease in Adult Lung Transplant Recipients." Transplant Infectious Disease, vol. 26, no. 3, 2024, p. 1, https://doi.org/10.1111/tid.14279.